SCHEMBL278931

SCHEMBL278931

C=C(/N=C/c1cc(Cl)ccc1OC1CCOCC1)O[Si](C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHEK1 O14757 2/20 0.38
SYK P43405 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
PDE4D Q08499 6/20 0.34
PDE4B Q07343 5/20 0.34
PDE4A P27815 4/20 0.34
PDE4C Q08493 4/20 0.34
CACNB4 O00305 1/20 0.34
CACNA1A O00555 1/20 0.34
CACNA1G O43497 1/20 0.34
CACNG3 O60359 1/20 0.34
CACNA1F O60840 1/20 0.34
CACNA1H O95180 1/20 0.34
CACNB3 P54284 1/20 0.34
CACNA2D1 P54289 1/20 0.34
CACNG7 P62955 1/20 0.34
CACNA1B Q00975 1/20 0.34
CACNA1D Q01668 1/20 0.34
CACNB1 Q02641 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL275247 1.00 CHEK1 (0.38) CHEK1SYKHPGDTSHRPDE4D
SCHEMBL274631 0.90 HPGD (0.36) HPGDTSHRPDE4DPDE4BPDE4A
SCHEMBL279490 0.90 HPGD (0.36) HPGDTSHRPDE4DPDE4BPDE4A
SCHEMBL279174 0.88 HPGD (0.38) HPGDTSHRPDE4BCACNB4CACNA1A
SCHEMBL274636 0.88 HPGD (0.38) HPGDTSHRPDE4BCACNB4CACNA1A
SCHEMBL276376 0.87 SYK (0.39) SYKPDE4DPDE4BPDE4APDE4C
SCHEMBL279161 0.87 SYK (0.39) SYKPDE4DPDE4BPDE4APDE4C
SCHEMBL276886 0.87 SYK (0.36) CHEK1SYKPDE4DPDE4BPDE4A
SCHEMBL278977 0.87 SYK (0.36) CHEK1SYKPDE4DPDE4BPDE4A
SCHEMBL278978 0.87 SYK (0.36) SYKHPGDTSHRPDE4DPDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8134001-B2 Spiroindolinone derivatives HOFFMANN-LA ROCHE INC. (US) 2012-03-13 US disclosed
US-20090156610-A1 Spiroindolinone Derivatives DING QINGJIE 2009-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090156610-A1 Spiroindolinone Derivatives SDHA, AR, XPOT CHEK1 1135/4885SYK 2511/4885HPGD 482/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.